These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 1982261)

  • 1. Serum hyaluronan concentration determined by radiometric assay in patients with pretibial myxedema and Graves' ophthalmopathy.
    Imai Y; Odajima R; Shimizu T; Shishiba Y
    Endocrinol Jpn; 1990 Oct; 37(5):749-52. PubMed ID: 1982261
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Euthyroid pretibial myxedema.
    Chen JJ; Ladenson PW
    Am J Med; 1987 Feb; 82(2):318-20. PubMed ID: 3812528
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunoglobulin A class fibroblast antibodies in patients with Graves' disease and pretibial myxedema.
    Arnold K; Metcalfe R; Weetman AP
    J Clin Endocrinol Metab; 1995 Dec; 80(12):3430-7. PubMed ID: 8530579
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunoglobulin G of patients with circumscribed pretibial myxedema of Graves' disease stimulates proteoglycan synthesis in human skin fibroblasts in culture.
    Shishiba Y; Imai Y; Odajima R; Ozawa Y; Shimizu T
    Acta Endocrinol (Copenh); 1992 Jul; 127(1):44-51. PubMed ID: 1519422
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence for thyrotropin receptor immunoreactivity in pretibial connective tissue from patients with thyroid-associated dermopathy.
    Daumerie C; Ludgate M; Costagliola S; Many MC
    Eur J Endocrinol; 2002 Jan; 146(1):35-8. PubMed ID: 11751064
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IgG, IgA and C3 deposits in the extra-thyroidal manifestations of autoimmune Graves' disease: their in vitro solubilization by intravenous immunoglobulin.
    Antonelli A; Palla R; Casarosa L; Fallahi P; Baschieri L
    Clin Exp Rheumatol; 1996; 14 Suppl 15():S31-5. PubMed ID: 8828945
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pretibial myxedema and high-dose intravenous immunoglobulin treatment.
    Antonelli A; Navarranne A; Palla R; Alberti B; Saracino A; Mestre C; Roger P; Agostini S; Baschieri L
    Thyroid; 1994; 4(4):399-408. PubMed ID: 7711502
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thyroid-stimulating antibody is related to Graves' ophthalmopathy, but thyrotropin-binding inhibitor immunoglobulin is related to hyperthyroidism in patients with Graves' disease.
    Noh JY; Hamada N; Inoue Y; Abe Y; Ito K; Ito K
    Thyroid; 2000 Sep; 10(9):809-13. PubMed ID: 11041459
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TSH receptor transcripts and TSH receptor-like immunoreactivity in orbital and pretibial fibroblasts of patients with Graves' ophthalmopathy and pretibial myxedema.
    Stadlmayr W; Spitzweg C; Bichlmair AM; Heufelder AE
    Thyroid; 1997 Feb; 7(1):3-12. PubMed ID: 9086563
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Graves' autoantibodies to extrathyroidal TSH receptor: their role in ophthalmopathy and pretibial myxedema.
    Rotella CM; Alvarez F; Kohn LD; Toccafondi R
    Acta Endocrinol Suppl (Copenh); 1987; 281():344-7. PubMed ID: 3475915
    [No Abstract]   [Full Text] [Related]  

  • 11. Patient with monoclonal gammopathy, thyrotoxicosis, pretibial myxedema and thyroid-associated ophthalmopathy; demonstration of direct binding of autoantibodies to the thyrotropin receptor.
    Tonacchera M; Costagliola S; Cetani F; Ducobu J; Stordeur P; Vassart G; Ludgate M
    Eur J Endocrinol; 1996 Jan; 134(1):97-103. PubMed ID: 8590966
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A case of pretibial myxedema associated with Graves' disease: an immunohistochemical study of serum-derived hyaluronan-associated protein.
    Shishido M; Kuroda K; Tsukifuji R; Fujita M; Shinkai H
    J Dermatol; 1995 Dec; 22(12):948-52. PubMed ID: 8648004
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Orbital decompression in Graves' ophthalmopathy associated with pretibial myxedema.
    Fatourechi V; Garrity JA; Bartley GB; Bergstralh EJ; Gorman CA
    J Endocrinol Invest; 1993 Jun; 16(6):433-7. PubMed ID: 8370919
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TSH and TSH receptor antibody-binding sites in fibroblasts of pretibial myxedema are related to the extracellular domain of entire TSH receptor.
    Chang TC; Wu SL; Hsiao YL; Kuo ST; Chien LF; Kuo YF; Change CC; Chang TJ
    Clin Immunol Immunopathol; 1994 Apr; 71(1):113-20. PubMed ID: 8137554
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Localized myxedema on the nasal dorsum in a patient with Graves' disease: report of a case.
    Akasu F; Takazawa K; Akasu R; Onaya T
    J Endocrinol Invest; 1989 Nov; 12(10):717-21. PubMed ID: 2575623
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low response of the thyroid gland to endogenous thyrotropin increased by thyrotropin-releasing hormone in patients with euthyroid Graves' disease.
    Kashiwai T; Tada H; Watanabe Y; Shimaoka Y; Yagoro A; Hidaka Y; Fujikado T; Amino N
    Thyroid; 1998 Oct; 8(10):881-5. PubMed ID: 9827654
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Graves' ophthalmopathy in the absence of elevated free thyroxine and triiodothyronine levels: prevalence, natural history, and thyrotropin receptor antibody levels.
    Khoo DH; Eng PH; Ho SC; Tai ES; Morgenthaler NG; Seah LL; Fong KS; Chee SP; Choo CT; Aw SE
    Thyroid; 2000 Dec; 10(12):1093-100. PubMed ID: 11201855
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autoantibodies to the flavoprotein subunit of succinate dehydrogenase: analysis of specificity in autoimmune thyroid disease.
    Kemp EH; Ridgway JN; Smith KA; Watson PF; Weetman AP
    Clin Endocrinol (Oxf); 2000 Sep; 53(3):291-9. PubMed ID: 10971445
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of plasmapheresis and steroid treatment on thyrotropin binding inhibitory immunoglobulins in a patient with exophthalmos and a patient with pretibial myxedema.
    Kuzuya N; DeGroot LJ
    J Endocrinol Invest; 1982; 5(6):373-8. PubMed ID: 6132943
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum immunoglobulin G4 levels and Graves' disease phenotype.
    Martin CS; Sirbu AE; Betivoiu MA; Florea S; Barbu CG; Fica SV
    Endocrine; 2017 Feb; 55(2):478-484. PubMed ID: 27819113
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.